{
    "2019-08-15": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Frozen assets: How a startup wants to cryobank your cells to fight cancer in the future",
                "features": {
                    "keywords": [
                        "cryobank",
                        "cells",
                        "fight cancer",
                        "startup"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Epizyme (EPZM) Focuses on Developing Lead Drug Tazemetostat",
                "features": {
                    "keywords": [
                        "Epizyme",
                        "Tazemetostat",
                        "drug development"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novartis replaces top scientists at Avexis after drug data manipulated",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Avexis",
                        "data manipulation",
                        "scientists"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "PRESS DIGEST- Financial Times - Aug 15",
                "features": {
                    "keywords": [
                        "Financial Times",
                        "Press Digest"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}